Metabolomic Diagnostics Secures $1million in Second Round Funding
News Feb 13, 2015
Metabolomic Diagnostics has secured an additional €750,000 in venture funding bringing the total investment in the company in the past year to €1.5m.
The SOSventures Ireland Fund, as well as the AIB Seed Capital Fund and Enterprise Ireland, have invested in the company, which has developed novel, predictive diagnostic tests for the early detection of pre-eclampsia during pregnancy.
Based in the Hoffmann Business Park, Little Island, Co Cork, Metabolomic Diagnostics currently employs seven people.
“The second round of funding shows the sustained confidence in our pre-eclampsia tests, which are being developed at our site in Little Island in Cork,” said Charles Garvey, CEO Metabolomic Diagnostics.
“With almost 80,000 deaths each year globally as a result of pre-eclampsia, this technology has the potential to save lives and revolutionize pre-natal care.”
Pre-eclampsia is characterized by rapidly increasing blood pressure and elevated protein in urine and once it escalates, the only treatment option is the delivery of the baby, often prematurely.
The result of significant research into metabolomic biomarkers, the diagnostic blood test will be able to detect the risk of pre-eclampsia early on in the pregnancy and ultimately save the lives of women and their babies through personalized medical interventions.
Retrained Enzyme is Biocatalysis MilestoneNews
TU Graz researchers managed for the first time ever to ‘retrain’ an enzyme to build ring-shaped molecular structures instead of performing its natural task of reducing double bonds. The work was published in Angewandte Chemie, and is relevant for the production of pharmaceuticals and plant protection products.
Laser Pulses and Fluorescence Enable Metabolite ViewingNews
In the search for new sources of drugs, biodegradables and biofuels scientists have come to realize that life itself could be the solution, using natural metabolites produced by bacteria to produce vital compounds like penicillin. Identifying which cells are most useful for this goal has proved a huge challenge, but a new system using fluorescence and lasers has enabled metabolite viewing in real time in algae cells.READ MORE
Comments | 0 ADD COMMENT
12th International Conference on Advancements in Bioinformatics and Drug Discovery
Nov 26 - Nov 27, 2018